SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Bogusz Patricia

(Last) (First) (Middle)
100 CLEARBROOK ROAD

(Street)
ELMSFORD NY 10523

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
BioScrip, Inc. [ BIOS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Vice President, Finance
3. Date of Earliest Transaction (Month/Day/Year)
05/14/2012
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, Par Value $0.0001 Per Share 05/14/2012 M 5,000 A $6.49 8,028 D
Common Stock, Par Value $0.0001 Per Share 05/14/2012 M 9,000 A $2.47 17,028 D
Common Stock, Par Value $0.0001 Per Share 05/14/2012 S 14,000(2) D $7.52 3,028 D
Common Stock, $.0001 Par Value(3) 7,875 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option $6.49 05/14/2012 M 5,000 10/24/2006(1) 10/24/2015 Common Stock, $.0001 Par Value 5,000 $0 0 D
Employee Stock Option $2.47 05/14/2012 M 9,000 11/01/2007(1) 11/01/2016 Common Stock, $.0001 Par Value 9,000 $0 0 D
Employee Stock Option $6.52 04/29/2009(1) 04/29/2018 Common Stock, $.0001 Par Value 19,687 19,687 D
Employee Stock Option $2.73 04/28/2010(1) 04/28/2019 Common Stock, $.0001 Par Value 20,000 20,000 D
Employee Stock Option $6.46 07/27/2011(1) 07/27/2020 Common Stock, $.0001 Par Value 10,000 10,000 D
Employee Stock Option $4.24 03/01/2012(1) 03/01/2021 Common Stock, $.0001 Par Value 20,000 20,000 D
Employee Stock Option $4.42 04/26/2012 04/26/2021 Common Stock, $.0001 Par Value 50,000 50,000 D
Employee Stock Option $6.62 03/08/2013 03/08/2022 Common Stock, $.0001 Par Value 100,000 100,000 D
Explanation of Responses:
1. Vests and becomes exercisable in three equal annual installments commencing on the first anniversary of the date of grant.
2. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.51 to $7.59 inclusive. The reporting person undertakes to provide to BioScrip, Inc., any security holder of BioScrip, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges forth in this footnote.
3. Unvested
/s/ Patricia Bogusz 05/17/2012
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.